Disc Medicine (IRON) Invested Capital (2020 - 2026)

Disc Medicine (IRON) has 6 years of Invested Capital data on file, last reported at $30.0 million in Q1 2026.

• On a quarterly basis, Invested Capital changed 0.0% year-over-year to $30.0 million in Q1 2026; TTM through Mar 2026 was $120.0 million, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $30.0 million, changed 0.0% from the prior year.
• Invested Capital for Q1 2026 stood at $30.0 million, roughly flat from $30.0 million in the prior quarter.
• Over the last five years, Invested Capital for IRON reached as high as $30.0 million in Q4 2024 and fell as low as $2.9 million in Q2 2022.
• Historically, Invested Capital has averaged $23.4 million across 4 years, with a median of $30.0 million in 2024.
• Across the five-year window, Invested Capital plunged 41.74% in 2022 and changed 0.0% in 2025, its largest moves.
• Year by year, Invested Capital stood at $2.9 million in 2022, then soared by 929.87% to $30.0 million in 2024, then changed by 0.0% to $30.0 million in 2025, then changed by 0.0% to $30.0 million in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $30.0 million in Q1 2026, $30.0 million in Q4 2025, and $30.0 million in Q3 2025.